vs
Apellis Pharmaceuticals, Inc.（APLS）与NWPX Infrastructure, Inc.（NWPX）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是NWPX Infrastructure, Inc.的1.4倍（$199.9M vs $138.3M），NWPX Infrastructure, Inc.净利率更高（7.6% vs -29.5%，领先37.1%），NWPX Infrastructure, Inc.同比增速更快（19.1% vs -5.9%），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 3.3%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
APLS vs NWPX — 直观对比
营收规模更大
APLS
是对方的1.4倍
$138.3M
营收增速更快
NWPX
高出25.0%
-5.9%
净利率更高
NWPX
高出37.1%
-29.5%
两年增速更快
APLS
近两年复合增速
3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $138.3M |
| 净利润 | $-59.0M | $10.5M |
| 毛利率 | — | 19.3% |
| 营业利润率 | -25.6% | 9.2% |
| 净利率 | -29.5% | 7.6% |
| 营收同比 | -5.9% | 19.1% |
| 净利润同比 | -62.2% | 165.7% |
| 每股收益（稀释后） | $-0.40 | $1.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSNWPX
| Q1 26 | — | $138.3M | ||
| Q4 25 | $199.9M | $125.6M | ||
| Q3 25 | $458.6M | $151.1M | ||
| Q2 25 | $178.5M | $133.2M | ||
| Q1 25 | $166.8M | $116.1M | ||
| Q4 24 | $212.5M | $119.6M | ||
| Q3 24 | $196.8M | $130.2M | ||
| Q2 24 | $199.7M | $129.5M |
净利润APLSNWPX
| Q1 26 | — | $10.5M | ||
| Q4 25 | $-59.0M | $8.9M | ||
| Q3 25 | $215.7M | $13.5M | ||
| Q2 25 | $-42.2M | $9.1M | ||
| Q1 25 | $-92.2M | $4.0M | ||
| Q4 24 | $-36.4M | $10.1M | ||
| Q3 24 | $-57.4M | $10.3M | ||
| Q2 24 | $-37.7M | $8.6M |
毛利率APLSNWPX
| Q1 26 | — | 19.3% | ||
| Q4 25 | — | 21.3% | ||
| Q3 25 | — | 21.3% | ||
| Q2 25 | — | 19.0% | ||
| Q1 25 | — | 16.7% | ||
| Q4 24 | — | 18.8% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | — | 19.9% |
营业利润率APLSNWPX
| Q1 26 | — | 9.2% | ||
| Q4 25 | -25.6% | 10.4% | ||
| Q3 25 | 48.7% | 12.6% | ||
| Q2 25 | -18.6% | 9.9% | ||
| Q1 25 | -50.0% | 4.8% | ||
| Q4 24 | -12.3% | 8.8% | ||
| Q3 24 | -24.0% | 11.9% | ||
| Q2 24 | -14.7% | 10.5% |
净利率APLSNWPX
| Q1 26 | — | 7.6% | ||
| Q4 25 | -29.5% | 7.1% | ||
| Q3 25 | 47.0% | 8.9% | ||
| Q2 25 | -23.6% | 6.8% | ||
| Q1 25 | -55.3% | 3.4% | ||
| Q4 24 | -17.1% | 8.4% | ||
| Q3 24 | -29.2% | 7.9% | ||
| Q2 24 | -18.9% | 6.7% |
每股收益（稀释后）APLSNWPX
| Q1 26 | — | $1.08 | ||
| Q4 25 | $-0.40 | $0.88 | ||
| Q3 25 | $1.67 | $1.38 | ||
| Q2 25 | $-0.33 | $0.91 | ||
| Q1 25 | $-0.74 | $0.39 | ||
| Q4 24 | $-0.30 | $1.00 | ||
| Q3 24 | $-0.46 | $1.02 | ||
| Q2 24 | $-0.30 | $0.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $14.3M |
| 总债务越低越好 | — | $10.7M |
| 股东权益账面价值 | $370.1M | $403.7M |
| 总资产 | $1.1B | $634.1M |
| 负债/权益比越低杠杆越低 | — | 0.03× |
8季度趋势，按日历期对齐
现金及短期投资APLSNWPX
| Q1 26 | — | $14.3M | ||
| Q4 25 | $466.2M | $2.3M | ||
| Q3 25 | $479.2M | $2.7M | ||
| Q2 25 | $370.0M | $2.0M | ||
| Q1 25 | $358.4M | $5.3M | ||
| Q4 24 | $411.3M | $5.0M | ||
| Q3 24 | $396.9M | $5.7M | ||
| Q2 24 | $360.1M | $4.5M |
总债务APLSNWPX
| Q1 26 | — | $10.7M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益APLSNWPX
| Q1 26 | — | $403.7M | ||
| Q4 25 | $370.1M | $394.8M | ||
| Q3 25 | $401.2M | $386.4M | ||
| Q2 25 | $156.3M | $379.5M | ||
| Q1 25 | $164.2M | $378.5M | ||
| Q4 24 | $228.5M | $374.0M | ||
| Q3 24 | $237.1M | $362.4M | ||
| Q2 24 | $264.3M | $351.2M |
总资产APLSNWPX
| Q1 26 | — | $634.1M | ||
| Q4 25 | $1.1B | $579.6M | ||
| Q3 25 | $1.1B | $605.2M | ||
| Q2 25 | $821.4M | $592.6M | ||
| Q1 25 | $807.3M | $582.2M | ||
| Q4 24 | $885.1M | $589.7M | ||
| Q3 24 | $901.9M | $617.2M | ||
| Q2 24 | $904.5M | $631.7M |
负债/权益比APLSNWPX
| Q1 26 | — | 0.03× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $29.3M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 2.78× |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSNWPX
| Q1 26 | — | $29.3M | ||
| Q4 25 | $-14.2M | $36.0M | ||
| Q3 25 | $108.5M | $21.0M | ||
| Q2 25 | $4.4M | $5.4M | ||
| Q1 25 | $-53.4M | $4.8M | ||
| Q4 24 | $19.4M | $36.1M | ||
| Q3 24 | $34.1M | $22.7M | ||
| Q2 24 | $-8.3M | $22.3M |
自由现金流APLSNWPX
| Q1 26 | — | — | ||
| Q4 25 | $-14.3M | $30.8M | ||
| Q3 25 | $108.3M | $13.2M | ||
| Q2 25 | $4.4M | $1.9M | ||
| Q1 25 | $-53.4M | $1.2M | ||
| Q4 24 | $19.3M | $31.9M | ||
| Q3 24 | — | $16.8M | ||
| Q2 24 | $-8.4M | $16.2M |
自由现金流率APLSNWPX
| Q1 26 | — | — | ||
| Q4 25 | -7.1% | 24.5% | ||
| Q3 25 | 23.6% | 8.7% | ||
| Q2 25 | 2.5% | 1.4% | ||
| Q1 25 | -32.0% | 1.0% | ||
| Q4 24 | 9.1% | 26.7% | ||
| Q3 24 | — | 12.9% | ||
| Q2 24 | -4.2% | 12.5% |
资本支出强度APLSNWPX
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 4.1% | ||
| Q3 25 | 0.0% | 5.2% | ||
| Q2 25 | 0.0% | 2.6% | ||
| Q1 25 | 0.0% | 3.2% | ||
| Q4 24 | 0.0% | 3.5% | ||
| Q3 24 | 0.0% | 4.6% | ||
| Q2 24 | 0.0% | 4.7% |
现金转化率APLSNWPX
| Q1 26 | — | 2.78× | ||
| Q4 25 | — | 4.06× | ||
| Q3 25 | 0.50× | 1.55× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.22× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 2.22× | ||
| Q2 24 | — | 2.58× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
NWPX
| Water Transmission Systems | $93.5M | 68% |
| Precast Infrastructure and Engineered Systems | $44.8M | 32% |
